Cacti Asset Management Trimmed By $2.01 Million Its Cvs Caremark (CVS) Holding; MYDX (MYDX) SI Increased By 50.97%

CVS Health Corporation (NYSE:CVS) Logo

MYDX INC (OTCMKTS:MYDX) had an increase of 50.97% in short interest. MYDX’s SI was 101,300 shares in April as released by FINRA. Its up 50.97% from 67,100 shares previously. It closed at $0.0033 lastly. It is up 0.00% since April 22, 2017 and is . It has underperformed by 11.55% the S&P500.

Cacti Asset Management Llc decreased Cvs Caremark Corporation (CVS) stake by 4.85% reported in 2017Q4 SEC filing. Cacti Asset Management Llc sold 27,945 shares as Cvs Caremark Corporation (CVS)’s stock declined 17.45%. The Cacti Asset Management Llc holds 548,308 shares with $39.75M value, down from 576,253 last quarter. Cvs Caremark Corporation now has $66.20B valuation. The stock decreased 0.37% or $0.24 during the last trading session, reaching $65.12. About 6.17M shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since April 22, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

MyDx, Inc. operates as a consumer products and data analytics firm leveraging proprietary science and technology to develop consumer products focusing on the cannabis industry. The company has market cap of $6.25 million. It focuses on four business divisions: Consumer Products, Data Analytics, Biopharmaceutical, and Software as a Service . It currently has negative earnings. The Consumer Products segment provides smart devices and consumables, including CannaDx sensors, delivery devices, and MyDx 2 sensors.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health has $132 highest and $73 lowest target. $96.48’s average target is 48.16% above currents $65.12 stock price. CVS Health had 76 analyst reports since July 22, 2015 according to SRatingsIntel. Argus Research maintained the stock with “Buy” rating in Monday, August 10 report. Robert W. Baird downgraded the shares of CVS in report on Thursday, February 2 to “Neutral” rating. Jefferies maintained the stock with “Hold” rating in Friday, September 15 report. The company was maintained on Tuesday, June 13 by Cowen & Co. On Monday, December 12 the stock rating was downgraded by Jefferies to “Hold”. The firm has “Hold” rating given on Friday, September 8 by Needham. The firm has “Neutral” rating by Goldman Sachs given on Thursday, December 17. The rating was maintained by RBC Capital Markets on Wednesday, August 5 with “Outperform”. The rating was upgraded by Needham to “Buy” on Tuesday, January 30. S&P Research maintained CVS Health Corporation (NYSE:CVS) rating on Monday, November 2. S&P Research has “Strong Buy” rating and $112 target.

Investors sentiment decreased to 0.72 in 2017 Q4. Its down 0.16, from 0.88 in 2017Q3. It is negative, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Fisher Asset Mngmt Ltd Liability has invested 0.02% of its portfolio in CVS Health Corporation (NYSE:CVS). Chilton Investment Lc accumulated 3,391 shares. Franklin Street Nc holds 80,655 shares or 0.87% of its portfolio. Adirondack Com holds 0.5% or 9,538 shares in its portfolio. Andra Ap owns 130,448 shares for 0.21% of their portfolio. Vident Advisory Ltd accumulated 50,765 shares or 0.17% of the stock. Captrust Fincl has 0.36% invested in CVS Health Corporation (NYSE:CVS) for 81,397 shares. 864,198 are held by Korea Inv. 10 holds 0.4% of its portfolio in CVS Health Corporation (NYSE:CVS) for 23,039 shares. Cambridge Investment Advsr invested in 119,788 shares. American Century holds 1.45 million shares. Moreover, Panagora Asset Mgmt Inc has 0.58% invested in CVS Health Corporation (NYSE:CVS). Afam holds 0.36% in CVS Health Corporation (NYSE:CVS) or 45,335 shares. Westwood Corp Il has invested 0.04% of its portfolio in CVS Health Corporation (NYSE:CVS). Silvercrest Asset Management Group Lc has invested 0.36% in CVS Health Corporation (NYSE:CVS).

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart